Below are the most recent publications written about "Neutrophils" by people in Profiles.
-
Teague HL, Warner S, Platt AP, Stein S, Ramos-Benitez MJ, Ramelli S, Curran S, Lach I, Allen K, Adetola H, Stantliff T, da Cruz RS, Minai M, Kendall H, Vannella KM, Alves DA, Herbert R, Chertow DS, Strich JR. Elevated Spleen Tyrosine Kinase in Low-Density Neutrophils During Bacterial Sepsis in a Nonhuman Primate Model. J Infect Dis. 2025 Dec 20; 232(6):e941-e952.
-
Subia NT, Awamura TK, Dean LS, Loftis K, Gangcuangco LM, MacPherson I, Chang S, Chow DC, Shikuma CM, Park J. Dysregulation of complement components associated with inflammation and coagulation in virally suppressed people living with HIV. J Immunol. 2025 Nov 01; 214(11):2871-2880.
-
Lee HJ, Lee NK, Kim J, Kim J, Seo D, Shin HE, Kim J, Ahn JH, Kim SN, Kim HS, Park J, Park W, Hong KS, Park CG, Lee W. Sequential nanoparticle therapy targeting neutrophil hyperactivation to prevent neutrophil-induced pulmonary fibrosis. J Nanobiotechnology. 2025 May 26; 23(1):381.
-
Caro-Rivera LM, Malavez-Cajigas S, Lacourt-Ventura M, Rivera-Torres AP, Marcano-Jim?nez DE, L?pez-Colon P, Mu?iz-Hern?ndez J, Rivera-Jim?nez E, Egozcue-Dionisi M, Rom?n-Carlo R, De Jes?s-Rojas W, Ramos-Ben?tez MJ. Age-related neutrophil activation in Hermansky-Pudlak Syndrome Type-1. Orphanet J Rare Dis. 2025 May 12; 20(1):226.
-
Smith AK, Katrinli S, Maihofer AX, Aiello AE, Baker DG, Boks MP, Brick LA, Chen CY, Dalvie S, Fani N, Fortier CB, Gelernter J, Geuze E, Gillespie CF, Hayes JP, Hong S, Kessler RC, King AP, Koen N, Koenen KC, Liberzon I, Linnstaedt SD, McLean SA, Michopoulos V, Milberg WP, Miller MW, Mufford MS, Nugent NR, Orcutt HK, Powers A, Rauch SAM, Ressler KJ, Risbrough VB, Rutten BPF, Smoller JW, Stein DJ, Stein MB, Ursano RJ, Verfaellie MH, Vermetten E, Vinkers CH, Wani AH, WareVinkers EB, Wildman DE, Wolf EJ, Zhao Y, Logue MW, Nievergelt CM, Uddin M, Zannas AS. Cell-type-specific and inflammatory DNA methylation patterns associated with PTSD. Brain Behav Immun. 2025 Aug; 128:540-548.
-
Shin HE, Giannakopoulos S, Park JD, Jang HJ, Park CG, Murphy SV, Park J, Verma S, Park W. Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation. J Control Release. 2025 Jun 10; 382:113736.
-
Cabrera-Fuentes HA, Boisvert WA. Refining the impact of early intermittent hyperlipidemia on atherosclerosis: Unveiling the role of neutrophil reprogramming, sex differences, gut microbiota, and maternal hypercholesterolemia. FASEB J. 2025 Mar 15; 39(5):e70425.
-
Raghavan P, Perez CA, Sorrentino TA, Kading JC, Finbloom JA, Desai TA. Physicochemical Design of Nanoparticles to Interface with and Degrade Neutrophil Extracellular Traps. ACS Appl Mater Interfaces. 2025 Feb 12; 17(6):8862-8874.
-
Giannakopoulos S, Park J, Pak J, Tallquist MD, Verma S. Post-COVID pulmonary injury in K18-hACE2 mice shows persistent neutrophils and neutrophil extracellular trap formation. Immun Inflamm Dis. 2024 08; 12(8):e1343.
-
Warner S, Teague HL, Ramos-Benitez MJ, Panicker S, Allen K, Gairhe S, Moyer T, Parachalil Gopalan B, Douagi I, Shet A, Kanthi Y, Suffredini AF, Chertow DS, Strich JR. R406 reduces lipopolysaccharide-induced neutrophil activation. Cell Immunol. 2024 Sep-Oct; 403-404:104860.